Can low ferritin be a cause of restless legs syndrome?

Yes, low ferritin is a well-established cause of restless legs syndrome (RLS) and should be routinely assessed and corrected.

Iron deficiency, reflected by low serum ferritin, is one of the most important treatable causes of RLS, and correcting it can significantly improve or even resolve symptoms. The 2025 AASM guidelines strongly recommend iron supplementation for RLS patients with appropriate iron parameters 1.

Iron Parameters That Matter for RLS

The iron thresholds for RLS are different and higher than for general anemia screening:

• Adults: Treat if ferritin < 75-100 ng/mL (some centers use < 100 ng/mL as cutoff) 1
• Children: Treat if ferritin < 50 ng/mL 1
• RLS with ESRD: Treat if ferritin < 200 ng/mL AND transferrin saturation < 20% 1

Critical caveat: Different ferritin assays yield different absolute values. A Beckman assay reading of 100 μg/dL equals approximately 158 μg/dL on a Roche assay 2. Know which assay your lab uses and adjust thresholds accordingly to avoid undertreating patients.

Evidence Supporting the Iron-RLS Connection

Multiple lines of evidence confirm this relationship:

• Severity correlation: Lower ferritin levels correlate with more severe RLS symptoms and worse sleep efficiency. Nearly all patients with severe RLS had ferritin ≤ 50 mcg/L 3
• Treatment response: Elderly patients with RLS and low ferritin showed significant symptom improvement with oral iron, with greatest benefit in those with ferritin ≤ 18 mcg/L 4
• Augmentation risk: Low ferritin increases risk of dopaminergic augmentation (treatment failure), making iron correction even more critical 5

Treatment Approach Based on Iron Status

For Adults with RLS:

First-line iron therapy (in order of recommendation strength):

1. IV ferric carboxymaltose - Strong recommendation for ferritin < 75-100 ng/mL 1
2. Oral ferrous sulfate - Conditional recommendation, particularly effective when ferritin is low-normal (< 50 ng/mL) 1, 6
3. IV low molecular weight iron dextran or ferumoxytol - Conditional recommendations 1

Emerging evidence: IV iron may benefit patients even with ferritin 100-300 μg/L, showing similar symptom improvement without causing iron overload 7. This challenges current cutoffs and suggests broader application.

For Children with RLS:

Ferrous sulfate is recommended when ferritin < 50 ng/mL 1. One pediatric study showed modest improvement in restless sleep symptoms with iron supplementation despite significant ferritin increases, though results weren't statistically significant in the definite RLS subgroup 8.

Oral vs IV Iron:

• Oral iron (ferrous sulfate + vitamin C) works best when ferritin is truly low (< 50 ng/mL) but is limited by poor absorption above this level and GI side effects 1, 6
• IV iron doesn't rely on GI absorption, penetrates the CNS more effectively (especially slow-release, high-dose formulations), and is strongly recommended for moderate-severe RLS 1

Why This Matters Clinically

Brain iron deficiency is a leading pathophysiologic mechanism in RLS 1. Correcting systemic iron stores can:

• Reduce or eliminate RLS symptoms
• Prevent dopaminergic augmentation (a major cause of treatment failure)
• Allow avoidance of dopamine agonists, which are now recommended against as standard therapy due to augmentation risk 1

Practical Algorithm

1. Check iron studies on all RLS patients: ferritin, transferrin saturation, serum iron
2. If ferritin < 75-100 ng/mL in adults (or < 50 ng/mL in children):
   • Consider IV ferric carboxymaltose 1000 mg (strongest evidence)
   • Alternative: oral ferrous sulfate if ferritin very low and patient prefers oral route
3. If ferritin 100-300 ng/mL with moderate-severe symptoms: Consider IV iron based on emerging evidence 7
4. Recheck ferritin after treatment and maintain levels > 75-100 ng/mL
5. Address other exacerbating factors: caffeine, alcohol, antihistamines, SSRIs, antipsychotics, untreated sleep apnea 1

Bottom line: Always screen for and correct iron deficiency before initiating other RLS medications. This simple intervention can be disease-modifying and prevent the need for chronic pharmacotherapy with its attendant risks.